These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 17559755

  • 21. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
    Gaynor PJ, Gopal M, Zheng W, Martinez JM, Robinson MJ, Hann D, Marangell LB.
    Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
    [Abstract] [Full Text] [Related]

  • 22. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
    Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M.
    J Sex Med; 2007 Jul; 4(4 Pt 1):917-29. PubMed ID: 17627739
    [Abstract] [Full Text] [Related]

  • 23. A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD).
    Baldwin DS, Loft H, Dragheim M.
    Eur Neuropsychopharmacol; 2012 Jul; 22(7):482-91. PubMed ID: 22209361
    [Abstract] [Full Text] [Related]

  • 24. Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.
    Signorovitch J, Ramakrishnan K, Ben-Hamadi R, Yu AP, Wu EQ, Dworak H, Erder MH.
    Curr Med Res Opin; 2011 Jun; 27(6):1089-96. PubMed ID: 21438794
    [Abstract] [Full Text] [Related]

  • 25. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
    Gaynor PJ, Gopal M, Zheng W, Martinez JM, Robinson MJ, Marangell LB.
    Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
    [Abstract] [Full Text] [Related]

  • 26. [Severe forms of depression: the efficacy of escitalopram].
    Spadone C.
    Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
    [Abstract] [Full Text] [Related]

  • 27. [Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder--the navigade switch study].
    Schmitt L, Arbus C, Tonnoir B.
    Encephale; 2006 Apr; 32(2 Pt 1):270-7. PubMed ID: 16910629
    [Abstract] [Full Text] [Related]

  • 28. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
    Wade AG, Schlaepfer TE, Andersen HF, Kilts CD.
    J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
    [Abstract] [Full Text] [Related]

  • 29. [Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the "Boulenger" study].
    Chauvet-Gélinier JC.
    Encephale; 2010 Oct; 36(5):425-32. PubMed ID: 21035633
    [Abstract] [Full Text] [Related]

  • 30. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials.
    Li H, Li T, Li G, Luo J.
    Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715
    [Abstract] [Full Text] [Related]

  • 31. Escitalopram versus venlafaxine XR in the treatment of depression.
    Montgomery SA, Andersen HF.
    Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901
    [Abstract] [Full Text] [Related]

  • 32. Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting.
    Dolberg O, Larsson Lönn S, Kvist K.
    Curr Med Res Opin; 2014 Jul; 30(7):1301-7. PubMed ID: 24628498
    [Abstract] [Full Text] [Related]

  • 33. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.
    Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S.
    J Am Acad Child Adolesc Psychiatry; 2009 Jul; 48(7):721-729. PubMed ID: 19465881
    [Abstract] [Full Text] [Related]

  • 34. Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
    Nordström G, Despiegel N, Marteau F, Danchenko N, Maman K.
    J Med Econ; 2010 Jul; 13(3):516-26. PubMed ID: 20698748
    [Abstract] [Full Text] [Related]

  • 35. [Efficacy of escitalopram and severity of depression: new data].
    Spadone C.
    Encephale; 2009 Dec; 35(6):577-85. PubMed ID: 20004289
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.
    Dolder C, Nelson M, Stump A.
    Drugs Aging; 2010 Aug 01; 27(8):625-40. PubMed ID: 20658791
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of Tianeptine 25-50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study.
    Emsley R, Ahokas A, Suarez A, Marinescu D, Dóci I, Lehtmets A, Milanova V, Lee MS, Didi R, Araszkiewicz A, Sulaiman AH, Blanchot FP, Crutel VS, Antoine C, Penelaud PF.
    J Clin Psychiatry; 2018 Jul 03; 79(4):. PubMed ID: 29995359
    [Abstract] [Full Text] [Related]

  • 38. Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model.
    Montgomery SA, Loft H, Sánchez C, Reines EH, Papp M.
    Pharmacol Toxicol; 2001 May 03; 88(5):282-6. PubMed ID: 11393591
    [Abstract] [Full Text] [Related]

  • 39. Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial.
    Findling RL, Robb A, Bose A.
    J Child Adolesc Psychopharmacol; 2013 Sep 03; 23(7):468-80. PubMed ID: 24041408
    [Abstract] [Full Text] [Related]

  • 40. An open-label multicentric study of the tolerability and response to escitalopram treatment in Indian patients with major depressive disorder.
    Pinto C, Trivedi JK, Vankar GK, Sharma PS, Narasimha V.
    J Indian Med Assoc; 2007 Jul 03; 105(7):364, 366, 368 passim. PubMed ID: 18178988
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.